NO172581C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner

Info

Publication number
NO172581C
NO172581C NO874959A NO874959A NO172581C NO 172581 C NO172581 C NO 172581C NO 874959 A NO874959 A NO 874959A NO 874959 A NO874959 A NO 874959A NO 172581 C NO172581 C NO 172581C
Authority
NO
Norway
Prior art keywords
ketons
preparation
therapeutic active
analogy procedure
active tricyclic
Prior art date
Application number
NO874959A
Other languages
English (en)
Norwegian (no)
Other versions
NO874959L (no
NO874959D0 (no
NO172581B (no
Inventor
Ian Harold Coates
John Bradshaw
James Angus Bell
David Cedric Humber
George Blanch Ewan
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628473A external-priority patent/GB8628473D0/en
Priority claimed from GB878726537A external-priority patent/GB8726537D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO874959D0 publication Critical patent/NO874959D0/no
Publication of NO874959L publication Critical patent/NO874959L/no
Publication of NO172581B publication Critical patent/NO172581B/no
Publication of NO172581C publication Critical patent/NO172581C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO874959A 1986-11-28 1987-11-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner NO172581C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628473A GB8628473D0 (en) 1986-11-28 1986-11-28 Chemical compounds
GB878726537A GB8726537D0 (en) 1987-11-12 1987-11-12 Tricyclic ketones

Publications (4)

Publication Number Publication Date
NO874959D0 NO874959D0 (no) 1987-11-27
NO874959L NO874959L (no) 1988-05-30
NO172581B NO172581B (no) 1993-05-03
NO172581C true NO172581C (no) 1993-08-11

Family

ID=26291603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874959A NO172581C (no) 1986-11-28 1987-11-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner

Country Status (24)

Country Link
US (1) US4822881A (enExample)
AT (1) AT396933B (enExample)
AU (1) AU605805B2 (enExample)
BE (1) BE1001004A4 (enExample)
CA (1) CA1326032C (enExample)
CH (1) CH676120A5 (enExample)
CZ (1) CZ404591A3 (enExample)
DE (1) DE3740352A1 (enExample)
DK (1) DK169675B1 (enExample)
ES (1) ES2008360A6 (enExample)
FI (1) FI92062C (enExample)
FR (1) FR2611366B1 (enExample)
GB (1) GB2202530B (enExample)
GR (1) GR871809B (enExample)
HK (1) HK51591A (enExample)
IE (1) IE61510B1 (enExample)
IL (1) IL84635A (enExample)
IT (1) IT1211936B (enExample)
NL (1) NL8702851A (enExample)
NO (1) NO172581C (enExample)
NZ (1) NZ222725A (enExample)
PH (1) PH30436A (enExample)
SE (1) SE467255B (enExample)
SG (1) SG46591G (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US5202343A (en) * 1986-11-28 1993-04-13 Glaxo Group Limited Tricyclic ketones useful as HT3 -receptor antagonists
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5360800A (en) * 1987-09-03 1994-11-01 Glaxo Group Limited Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
JPH01258673A (ja) * 1987-10-22 1989-10-16 Glaxo Group Ltd ケトン誘導体
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
DK185489A (da) * 1988-04-22 1989-10-23 Duphar Int Res Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
EP0350129A1 (en) * 1988-07-07 1990-01-10 Duphar International Research B.V New annelated indoleketones with an imidazolylalkyl substituent
HU207078B (en) * 1988-08-02 1993-03-01 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds
NO169714C (no) * 1988-08-02 1992-07-29 Glaxo Group Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive laktamderivater
EP0356098A3 (en) * 1988-08-15 1990-07-25 Glaxo Group Limited Lactam derivatives
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
EP0357417A1 (en) * 1988-09-01 1990-03-07 Glaxo Group Limited Lactam derivatives
GB8820651D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
GB8820650D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
GB8823980D0 (en) * 1988-10-13 1988-11-23 Glaxo Group Ltd Chemical compounds
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same
GB8904552D0 (en) 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical process
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
ATE97803T1 (de) 1989-04-21 1993-12-15 Sandoz Ag Therapeutische verwendung von 5-ht3-rezeptorantagonisten.
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
KR100368895B1 (ko) * 2000-03-30 2003-01-24 하나제약 주식회사 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법
AU2003210610B2 (en) 2002-01-18 2007-11-29 Aryx Therapeutics 5-HT3 receptor antagonists and methods of use
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
KR101779991B1 (ko) 2009-05-20 2017-09-19 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 병소성 전정 질환을 치료하기 위한 세로토닌 5-ｈｔ3 수용체 길항제의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634420A (en) * 1969-05-09 1972-01-11 American Cyanamid Co 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
US3740404A (en) * 1969-05-09 1973-06-19 American Cyanamid Co Piperidinomethylenedihydrocarbazolones
GB1365296A (en) * 1970-10-30 1974-08-29 Unilever Ltd Dentifrice compositions
US4176230A (en) * 1977-08-04 1979-11-27 Hoffmann-La Roche Inc. 5-(6-Alkylindol-3-ylmethylene)-1,3-dimethyl-2-(methylimino)-4-imidazolidinones
BG33279A3 (en) * 1978-11-01 1983-01-14 The Wellcome Foundation Limited Method for making of carbazole compounds
DK151884C (da) * 1979-03-07 1988-06-13 Pfizer Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
NZ210940A (en) * 1984-01-25 1989-08-29 Glaxo Group Ltd 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
DE3740352A1 (de) 1988-06-09
NO874959L (no) 1988-05-30
CA1326032C (en) 1994-01-11
BE1001004A4 (fr) 1989-06-06
NZ222725A (en) 1990-08-28
ATA312487A (de) 1993-05-15
SE8704746L (sv) 1988-05-29
AU8184587A (en) 1988-06-02
DK624887A (da) 1988-05-29
IL84635A (en) 1993-01-31
IT1211936B (it) 1989-11-08
DK624887D0 (da) 1987-11-27
IE61510B1 (en) 1994-11-16
DK169675B1 (da) 1995-01-09
CZ404591A3 (en) 1993-08-11
PH30436A (en) 1997-05-09
AT396933B (de) 1993-12-27
HK51591A (en) 1991-07-12
ES2008360A6 (es) 1989-07-16
NO874959D0 (no) 1987-11-27
IL84635A0 (en) 1988-04-29
FI92062B (fi) 1994-06-15
FI875235A0 (fi) 1987-11-27
GB8727835D0 (en) 1987-12-31
SE467255B (sv) 1992-06-22
AU605805B2 (en) 1991-01-24
GR871809B (en) 1988-03-07
NL8702851A (nl) 1988-06-16
NO172581B (no) 1993-05-03
GB2202530A (en) 1988-09-28
CH676120A5 (enExample) 1990-12-14
GB2202530B (en) 1990-04-18
FR2611366B1 (fr) 1990-03-16
SE8704746D0 (sv) 1987-11-27
US4822881A (en) 1989-04-18
IE873232L (en) 1988-05-28
FR2611366A1 (fr) 1988-09-02
SG46591G (en) 1991-07-26
FI92062C (fi) 1994-09-26
FI875235A7 (fi) 1988-05-29
IT8748642A0 (it) 1987-11-27

Similar Documents

Publication Publication Date Title
NO172581C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske ketoner
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO173017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nor-statin- eller nor-cyklostatinpolypeptider
NO171913C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO871867D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO162617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater
NO162156C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.